Cyclic nucleotide phosphodiesterases and vascular smooth muscle.
about
Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.Cyclic GMP-dependent vasodilatory properties of LASSBio 294 in rat aortaSolid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents.Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function.Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.PDE9A is expressed in the inner retina and contributes to the normal shape of the photopic ERG waveform.The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recoveryAlteration of vascular reactivity in heart failure: role of phosphodiesterases 3 and 4.Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery.Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aortaThe proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.Phosphodiesterases Regulate BAY 41-2272-Induced VASP Phosphorylation in Vascular Smooth Muscle Cells.The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.Campomanesia adamantium Peel Extract in Antidiarrheal Activity: The Ability of Inhibition of Heat-Stable Enterotoxin by Polyphenols.Cardiovascular system as a 'core' of sexual life.Kv7.5 Potassium Channel Subunits Are the Primary Targets for PKA-Dependent Enhancement of Vascular Smooth Muscle Kv7 Currents.Comparative gene expression analysis of the human periodontal ligament in deciduous and permanent teeth.Expression, activity, and function of phosphodiesterases in the mature and immature ductus arteriosus.Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary arteryPDE4 and PDE5 regulate cyclic nucleotide contents and relaxing effects on carbachol-induced contraction in the bovine abomasum.Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats.Effects of modulating in vivo nitric oxide production on the incidence and severity of PDE4 inhibitor-induced vascular injury in Sprague-Dawley rats.Noninvasive assessment of acute cardiopulmonary effects of an oral single dose of sildenafil in patients with idiopathic pulmonary hypertension.Design, synthesis and pharmacological evaluation of 6-hydroxy-4-methylquinolin-2(1H)-one derivatives as inotropic agents.Phosphodiesterase 3 activity is reduced in dog lung following pacing-induced heart failure.Effect of PDE5 inhibition on coronary hemodynamics in pacing-induced heart failure.Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats.DA-8159, a new PDE5 inhibitor, attenuates the development of compensatory right ventricular hypertrophy in a rat model of pulmonary hypertension.Diabetes-related changes in cAMP-dependent protein kinase activity and decrease in relaxation response in rat mesenteric artery.Heterogeneity in endothelium-derived nitric oxide-mediated relaxation of different sized pulmonary arteries of newborn lambs.Nitric oxide induces phosphodiesterase 4B expression in rat pulmonary artery smooth muscle cells.
P2860
Q25255769-413ACB3C-34E4-4CCB-91D5-E9DD849C8FECQ28344915-8D580726-AB62-474F-8DDB-7EF0A28C1223Q31103106-81300ABB-3A09-4754-BE8D-C089EFA2BDA3Q31795335-C8E65AC0-E5A7-4CB0-957F-DC320999711FQ33784417-0DE44554-5ADA-411F-9C4D-2868F0FCF79CQ33814021-45780989-6FEB-4B5A-A7C2-0A842DF084FDQ34515590-074CF31D-C0FB-4488-94BC-E7076C334E29Q34953389-4BA471F8-2B5A-45EC-B97F-75B85E589EA9Q35045375-F2D9D066-2549-490D-AE2F-E2CE00571094Q35545232-420000DA-CBBC-4875-8E27-9C21B14E81DFQ35571071-4097A54B-5C8B-4194-9A32-E6590D283DC4Q35740400-702D8E4A-CD42-432F-9795-B916D25D32E4Q35993920-70D0918C-3225-4DE4-8CE6-717C4825A04FQ36169609-B1F63D88-4371-4216-9721-29E89C686B43Q36283716-F73A0D0D-90D2-4DE2-8078-DB0581AF40CEQ36618785-E37E7596-4701-4C67-A209-39BDABAA8978Q36750102-43434578-3AA7-431D-8F13-46007C187CFDQ37037036-2841C734-4E1E-45C7-9FF5-AD63E8C3945DQ39253159-12C701F0-B052-4728-9B36-94E48D32B398Q42255406-D2693B91-FE42-4343-AD23-6F85AB81AF11Q42461961-EC400DD7-4C54-4116-BCD1-E39685AE7A9CQ42742636-4555FBB1-4C86-410B-A6AB-4DAF18BD9ADBQ42949807-F9A610E7-E936-4C0C-BAB1-150F04F3469AQ44345043-08ABD2EE-585E-45BD-AB0F-E2D194FAE22DQ44391188-EA0F0C47-0485-4B1F-B26F-9B1E41D94CE8Q44392704-73EDFE78-1DD3-4DF1-B4F2-12C54B2E4801Q44470070-F3DCB5E7-02D6-4520-9D0B-008167A2F1C6Q44715956-BC629ED1-ABC7-4D2B-98DC-F2F18DE5CA72Q44886460-CAE9873F-0AF2-415C-A0E9-4E10B240899EQ46108220-72EF3D40-8C58-4278-97DA-479714A24D10Q46813266-ED5BD32A-2B74-43BE-BAD8-E0608EA59451
P2860
Cyclic nucleotide phosphodiesterases and vascular smooth muscle.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Cyclic nucleotide phosphodiesterases and vascular smooth muscle.
@en
type
label
Cyclic nucleotide phosphodiesterases and vascular smooth muscle.
@en
prefLabel
Cyclic nucleotide phosphodiesterases and vascular smooth muscle.
@en
P1476
Cyclic nucleotide phosphodiesterases and vascular smooth muscle.
@en
P2093
P304
P356
10.1146/ANNUREV.PA.36.040196.002155
P577
1996-01-01T00:00:00Z